ILD Flashcards
ILD aka
Diffuse Parenchymal Lung Disease (DPLD)
ILD lung damage
- irreversibly enlarged, damaged bronchioles and distorted alveoli
- honey combing (clustered cycstic air spaces)
- fibrosis between alveoli decreases gas exchange, reducing oxygen transfer
Causes of ILD
idiopathic
autoimmune (RA, scleroderma, sarcoidosis, sjogren)
hazardous material (asbestos, silica, droppings, radiation, hot tubs)
drugs (amiodarone, propanolol, nitrofurantoin, MTX, rituximab)
*generally irreversible
Pathophys of ILD
alveolar epithelium damage –> type 2 epithelial cells proliferate (to repair damage) –> repair leads to fibrosis and scarring –> lung stiffens, ability to transport O2 diminished –> hypoxemia
Sx of ILD
progressive DOE
persistent non-productive cough
wheezing and chest pain UNCOMMON
Extra-pulm sx: suggestive of CT disease; musculoskeletal pain, weakness, joint pain or swelling, fevers, dry eyes/mouth
PE for ILD
Crackles: “velcro”
inspiratory squeaks (high pitched rhonchi)
cor pulmonale - middle/late stages
cyanosis
digital clubbing** - advanced disease
extram pul: ereythema nodosum, gottrons papules
Erythema nodosum
sarcoidosis
Gottrons papules
dermatomyositis
Crackles
pneumo and ILD
clubbing
ILD
Dx of ILD
MDD: pulmonologist, radiologist, pathologist HRCT - best noninvasive Tissue bx = gold standard (rarely done) Sero studies - r/o autoimmune PFT ABG BAL
CXR in ILD
some normal
ground-glass appearance (non-specific)
reticular “netlike” - most common
Honeycombing (poor prognosis)
poor prognosis for ILD
honeycombing
Where is ILD in sarcoidosis
upper/central lung fields
Reticular opacities
IPF or asbestos
Ground glass
drug toxicity, respiratory bronchiolitis ILD
Serologic studies for ILD
ANA and RF: done 1st
if (+): Anti-ds-DNA for SLE
If pulm hemorrhage or suspect systemic sx, evaluate for vasculitis: ANCA!
Used to assess disease severity/progress in ILD
PFT
PFT in ILD
restrictive
- decreased TLC
- decreased FEV1 and FVC, but proportional changes lead to normal/increased FEV1/FVC ratio
PFT to dx ILD
PFT restrictive pattern + low DLCO
Which ILD has obstructive pattern?
sarcoidosis
Low DLCO
early finding
signifies alveolar damage- impaired gas exchange
ABG in ILD
normal or hypoxemia or respiratory alkalosis
- may need to perform exercise testing w/ serial ABGs
Bronchoalveolar Lavage (BAL)
sampling of distal airways and alveoli: cell counts, cultures, cytology
Cell count in ILD
eosinophilic pneumo
When to perform lavage
not typically performed w/ HRCT findings c/w IPF
Gold standard for dx of ILD
Lung Bx
Indications for lung bx
specifying dx (<50 yo, fever,, weight loss, hemoptysis, vasculitis)
atypical/rapidly progressing
unexplain extrapulm manifestations
exclude neoplasm or infection
identify a more treatable process
predict likelihood of response to therapy
Contraindication to lung bx
honeycombing
Types of Lung bx
transbronchial
surgical: Video assisted thorascopic surgery (VATS), thoracotomy
Endobronchial u/s-guided transbronchial needle aspiration (EBUS-TBNA)
Transbronchial bx
during bronchoscopy, bx forceps passed through bronchoscop; good for CENTRAL locations
VATS
two small incisions into lateral chest wall
less morbidity
Thoracotomy
5-6 cm incision required
EBUS-TBNA
special bronchoscope used to evaluate hilar and mediastinal lymph nodes
general anesthesia
done in conjunction w/ TBLB but need to pass different scope
When is EBUS-TBNA useful
if sarcoid suspected
Most common ILD
Idiopathic Pulmonary Fibrosis (IPF)
who gets IPF
> 50 yo
M>F
familial cases at younger age
POOR PROGNOSIS (2-5 yr survival)
Histopathology of IPF and asbestosis
Usual Interstitial Pneumonia (UIP)
Presentation of IPF
Gradual onset of exertional dyspnea and non-productive cough (>6 months)
Velcro crackles *(inspiratory)
Digital clubbing *
Dx of IPF
6-minute walk test CXR: reticular opacities in bases, honeycombing HRCT PFT: restrictive Bx NOT REQUIRED Echo: pulmonary HTN
New Dx criteria for IPF
HRCT: UIP pattern, probable, indeterminate or alt. UIP pattern
Lung Bx + BAL if: probable UIP, indetermintate UIP or alt. dx
Tx for IPF
consult: pulmonologist, MMD Poor tx options, not much work **Tx for GERD (even if not sx Nintedanib (TKI) Pirfenidone: reduced fibrosis by downregulation GF and procollagens Smoking cessation, UTD vaccines Supplemental O2 if needed`
Meds for IPF
Nintedanib
Pirfenidone
Who gets sarcoidosis
F>M
African Americans
ages 20-40
What is sarcoidosis
Non-caseating granulomas- secreted dihydroxyvitamin D, so serum levels elevated
Serum levels in sarcoidosis
elevated Ca and Vit D
Secrete ACE which acts as cytokine
Hx of sarcoidosis
DOE, chest pain, cough, hemoptysis (rare) systemic complains (fever, anorexia)
Extra pulm findings in sarcoidosis
erythema nodosum
Lupus pernio
granulomatous uveitis
arthralgia
Dx for sarcoidosis
Restrictive pattern
reduced DLCO
CXR: ADENOPATHY
Bx usually required: EBUS-TBLB
Labs for sarcoidosis
elevated serum ACE, Ca
hypercalciuria
elevated ALP
Staging of sarcoidosis
0- normal 1- hilar adenopathy 2- hilar adeno + diffus infiltrates 3- only diffuse parenchymal infiltrates 4- pulm fibrosis
Tx for sarcoidosis
consult
tx if >stage 2 and symptomatic
High dose corticosteroid (PJP prophylaxis)
MTX alternative
Chlroquine/hydroxychloroquine for cutaneous lesions, neuro manifestations, hypecalcemia
Topical steroids for ocular disease
Lung transplant in stage IV
Main drug for sarcoidosis
high dose corticosteroid (taper over 6 months)
What is pneumoconiosis?
general term for lung disease caused by inhalationa nd deposition of mineral dust
Types of pneumoconiosis
asbestosis
silicosis
coal worker’s pneumoconiosis
Silicosis
fibronodular lung disease
inhaling silica dust (alpha-quartz or silicone dioxide)
Occupations at risk for silicosis
MINING
construction
granite cutting
pottery making
CXR in silicosis
enlarging opacities even after exposure eliminated, can cavitate (r/o TB)
PFT in silicosis
restrictive
massive fibrosis leading to severe restriction
Chronic simple silicosis
10-12 yrs exposure
may be asymp.
non-progressive once exposure eliminated
Hilar node calcification (EGGSHELL PATTERN)
small round opacities (silicotic nodules)
Chronic complicated silicosis
> 20 yrs exposure
progressive even after exposure eliminated
tachypnea, prolonged expiration, rhonchi, wheezing, rales
clubbing uncommon
cyanosis
cor pulmonale
Eggshell pattern
chronic simple silicosis
Management of silicosis
consult no tx alters disease cource corticosteroids may benefit ACUTE phase eliminate exposure vaccinate elevated TB risk, treat latent TB eval for lung transplant candidacy
Asbestosis epidemiology
presents 15-20 yrs of exposure; dose-dependent
40-75 YO
<>F
occupation: construction, mechanics, pipefitters, plumbers, welders, janitors, shipyard, insulation workers
Asbestosis is associated w/
bronchogenic CA and malignant mesothelioma
PE for asbestosis
no specific s/sx insidious onset - dyspnea, reduced exercise tolerance, chest discomfort dry cough end-inspiratory rales digital clubbing
Dx for asbestosis
CXR: opacity in lower lung, thickened pleura, PLEURAL PLAQUES
Open lung bx: usually not indicated, provides definitive dx (asbestos bodies)
PFT: restrictive
Egg shell
silicosis
Pleural plaques
asbestosis
Pleural plaque location
diaphragmatic or parietal pleura of 6th-9th rib
Management of Asbestosis
consult- may need long term O2 No drugs alter disease Goal: eliminate progression, reduce risk of other disorders Vaccinate: influenza, pneumovax Promptly treat resp. infection evaluate lung lesions Prevention: avoid exposure, mask
Associated w/ high risk f or malignancy
asbestosis- smoking increases risk
Mesothelioma
CA almost ALWAYS associated w/ asbestos exposure
Mesothelioma epidemiology
short term exposure to asbestos (1-2 yrs) most common in pleura can occur in peritoneum or pericardium not caused by smoking poor prognosis (6-12 mo)
Vasculitic ILD
granulomatosis w/ polyangiitis (GPA)
GPA
immune-mediated systemic vasculitis of small-medium vessel
GPA aka
“ANCA-associated vasculitis”
GPA characterized by
necrotizing granulomas of upper and lower RT
Epidemiology of GPA
RARE northern european descent men = women 35-55 yo relapse common
Most common in african americans
sarcoidosis
Hx of GPA
recurrent resp infections
nonspecific constitutional sx: fever, weight loss, night sweats, loss of appetite, fatigue/lethargy
PE of GPA
ocular involvement: conjunctivitis, episcleritis, uveitis, RAO
ENT: chronic sinusitis, rhinitis, epistaxis, SADDLE NOSE
Pulm: infiltrates, cough, hemoptysis, dysnpea, stridor
MSK: arthralgia
Renal failure, erythrocyte casts
CN palsies, sensorimotor polyneuropathy
Skin: purpura, ulcers
Cardiac: pericarditis, coronary vasculitis
Necrotic blistering purpura
GPA
Saddle nose deformity
GPA
egg shell
silicosis
Pleural plaques
asbestosis
Dx of GPA
CXR: variable, nodules which may cavitate
HRCT: stellate shaped peripheral pulmonary arteris (“vasculitis”, feeding vessels leading to nodules/cavities, diffuse alveolar hemorrhage
Bronchoscopy: only indicated if hemorrhage or intervention (stenting)
Tissue bx: vasculitis, granulomatous inflammation
Labs for GPA
ESR/CRP elevated
CBC/CMP: normocytic anemia, thrombocytosis, leukocytosis, renal involvement (BUN/Cr)
UA: proteinuria, RBC casts (GN)
C-ANCA!
consider RF and ANA
C-ANCA
GPA
Management for GPA
consult rheum and pulm
cyclophosphamide (immunosuppressant) & corticosteroid
Cyclophosphamide toxicities
cardiac (CHF), heme (thrombocytopenia), renal (hemorrhagic cycstitis, tubular necrosis), GI (n/v/d)
Cyclophosphamide
used to treat GPA; improves prognosis
Hypersensitivity pneumonitis cause
repetitive inhalation of antigens in a susceptible host
Potential exposures for Hypersensitivity pneumonitis
Bacteria, fungi, mold
proteins, chemiicals
environmental (droppings, fur/feathers, hot tubs, hardwood, dust)
farmers, cattle, metalworkers, plastic manufactureres, grain/flour processor, vets
Reversible process
hypersensitivity pneumonitis (several years)
Hx for hypersensitivity pneumonitis
flu-like syndrom w/i hours of exposure if acute
insidious cough dyspnea, fatigue if subactue
progressive dyspnea, cough, fatigue, malaise in chronic
PE for hypersensitivity pneumonitis
diffuse, fine bibasilar crackles, fevers, tachypnea, muscle wasting, clubbing, weight loss
Imaging for hypersensitivity pneumonitis
interstitial inflammation, honeycombing, centrilobular fibrosis, peribronchiolar fibrosis
Management of hypersensitivity pneumonitis
consul pulm
antigen avoidance/prevention
acute disease: no tx
Corticosteroids in severe disease
Bronchodilators, antihistamines, ICS are adjunct tx
Complications of ILD
pulm HTN cor pulmonale/CVD (hypertrophy or dilation of RV) pneumothorax PE Pulmonary ifnection elevated cancer risk progressive resp. insufficiency
velco-like inspiratory crackles in bilateral bases
IPF
Bibasilar Reticulonodular opacities
IPF
hypercalcemia
sarcoidosis
hilar adenopathy
sarcoidosis
calcified pleural plaques
asbestosis
eggshell
silicosis